MDCX
Medicus Pharma Ltd.Company Information
- Company Name
- Medicus Pharma Ltd.
- CIK
- CIK0001997296
- Category
- <br>Emerging growth company
- Ticker: Exchange
- MDCX: Nasdaq, MDCXW: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- MDCX
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2025-05-20
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 75,000
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 2,596,654
- Shares outstanding
- 55,055,225
- Ownership
- 4.72%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- -48.04%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||
| Cash And Cash Equivalents At Carrying Value | 15 | 6 | 9 | 9 | 10 | 4 | 4 | ||||||
| Prepaid Expense Current | 2 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Deferred Costs Current | 0 | 0 | 0 | - | - | - | 0 | ||||||
| Assets Current | 17 | 7 | 10 | 10 | 11 | 5 | 5 | ||||||
| Restricted Cash Noncurrent | 10 | - | - | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Costs | - | - | - | - | 1 | 0 | - | ||||||
| Assets | 27 | 7 | 10 | 10 | 12 | 6 | 6 | ||||||
Liabilities Current | |||||||||||||
| Accounts Payable Current | 7 | 2 | 3 | 2 | 2 | 2 | 1 | ||||||
| Accrued Liabilities And Other Liabilities | 0 | 1 | 1 | 2 | 2 | 1 | 1 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Debt Current | - | 2 | 5 | 7 | 5 | - | 0 | ||||||
| Secured Debt Current | 4 | - | - | - | - | - | - | ||||||
| Liabilities Current | 11 | 6 | 10 | 11 | 9 | 3 | 2 | ||||||
| Secured Long Term Debt | 18 | - | - | - | - | - | - | ||||||
| Long Term Loans Payable | 0 | 0 | 0 | 0 | - | - | 0 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 29 | 6 | 10 | 11 | 9 | 4 | 3 | ||||||
Stockholders Equity | |||||||||||||
| Common Stock Value | 74 | 67 | 57 | 0 | 38 | 33 | 31 | ||||||
| Additional Paid In Capital | 9 | 7 | 7 | 6 | 6 | 3 | 2 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | -0 | 0 | 0 | - | - | 0 | ||||||
| Retained Earnings Accumulated Deficit | -85 | -73 | -64 | -0 | -40 | -34 | -29 | ||||||
| Stockholders Equity | -2 | 1 | 0 | -1 | 3 | 2 | 3 | ||||||
| Minority Interest | 0 | 0 | 0 | 0 | - | - | 0 | ||||||
| Liabilities And Stockholders Equity | 27 | 7 | 10 | 10 | 12 | 6 | 6 | ||||||
| Common Stock No Par Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Shares Authorized | 60 | 40 | 25 | - | - | - | 12 | ||||||
| Common Stock Shares Issued | 60 | 40 | 25 | 21 | 16 | 13 | 12 | ||||||
| Shares Outstanding | 60 | 40 | 25 | 21 | 16 | 13 | 12 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialMedicus Pharma Ltd. (MDCX) — SEC Financial Statements & Analysis
Medicus Pharma Ltd. (MDCX) is a pharmaceutical preparations company, incorporated in A6. Medicus Pharma Ltd. trades on Nasdaq as: MDCX, MDCXW. Medicus Pharma Ltd. (MDCX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, Medicus Pharma Ltd. carries a market cap of $24.55M, a P/E ratio of -0.44x, a P/B ratio of -14.23x, an enterprise value of $20.85M, and an EV/EBITDA multiple of -0.48x. On profitability, it posts a Return on Equity (ROE) of -7372.74% and a Return on Assets (ROA) of -287.68%. Per share, it reports EPS of $-1.02, diluted EPS of $-1.02, free cash flow per share of $-0.53, and a dividend per share of $0.00. On the balance sheet, it maintains a current ratio of 1.57x, a quick ratio of 1.40x, working capital of $6.14M, a debt-to-equity ratio of -16.72x, a debt ratio of 1.06, an interest coverage ratio of -51.49x, free cash flow of $-29.32M (TTM), and net debt of $-3.71M. Figures sourced from SEC EDGAR.
- Market Cap
- $24.55M
- P/E TTM
- -0.44x
- EPS TTM
- $-1.02
- P/B TTM
- -14.23x
- ROE TTM
- -7372.74%
- ROA TTM
- -287.68%
- Debt To Equity
- -16.72x
- Free Cash Flow TTM
- $-29.32M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Medicus Pharma Ltd. in?
Medicus Pharma Ltd. (MDCX) operates in the Pharmaceutical Preparations industry.
What exchange does MDCX trade on?
Medicus Pharma Ltd. (MDCX) trades on the Nasdaq.
Where is Medicus Pharma Ltd. incorporated?
Medicus Pharma Ltd. is incorporated in Ontario, Canada.
When was Medicus Pharma Ltd. (MDCX)'s most recent SEC filing?
Medicus Pharma Ltd. (MDCX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is MDCX's market cap?
Medicus Pharma Ltd. (MDCX) has a market capitalization of $24.55M as of 2026-06-30.
What is MDCX's EPS (earnings per share)?
Medicus Pharma Ltd. (MDCX)'s trailing twelve month EPS is $-1.02 as of 2026-06-30.
What is MDCX's ROE (return on equity)?
Medicus Pharma Ltd. (MDCX)'s trailing twelve month Return on Equity (ROE) is -7372.74% as of 2026-06-30.
What is MDCX's ROA (return on assets)?
Medicus Pharma Ltd. (MDCX)'s trailing twelve month Return on Assets (ROA) is -287.68% as of 2026-06-30.
What is MDCX's EV/EBITDA?
Medicus Pharma Ltd. (MDCX)'s trailing twelve month EV/EBITDA is -0.48x as of 2026-06-30.